Statement Of Cash Flows [Abstract]

argenx SE - Filing #1882803

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations before changes in working capital
462,093,000 USD
249,405,000 USD
379,643,000 USD
Adjustments for decrease (increase) in trade and other receivables
222,260,000 USD
31,632,000 USD
21,961,000 USD
Adjustments for increase (decrease) in trade and other payables
329,000 USD
134,892,000 USD
50,537,000 USD
Adjustments for decrease (increase) in other current assets
18,294,000 USD
30,990,000 USD
16,189,000 USD
Adjustments for amortisation expense
99,766,000 USD
776,000 USD
246,000 USD
Adjustments for depreciation expense
4,576,000 USD
5,091,000 USD
3,671,000 USD
Adjustments for gain (loss) on disposal of investments in subsidiaries, joint ventures and associates
677,000 USD
USD
USD
Cash flows from (used in) investing activities [abstract]
Purchase of investments other than investments accounted for using equity method
1,694,046,000 USD
USD
USD
Proceeds from sales of investments other than investments accounted for using equity method
1,325,540,000 USD
USD
USD
Cash flows from (used in) financing activities [abstract]
Proceeds from exercise of options
93,195,000 USD
33,433,000 USD
22,912,000 USD
Payments for share issue costs
781,000 USD
528,000 USD
613,000 USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.